10-K Decoder · All companies

Eton Pharmaceuticals, Inc.

ETON · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$80.0M$39.0M+105%
Operating income−$840K−$2.60M+67.7%
Net income−$4.60M−$3.82M−20.4%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$57.9M$22.5M+157%
Operating income$23.0M−$1.40M
Net income$35.2M−$1.90M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Eton Pharmaceuticals's revenue in FY2025?
$80.0M in FY2025 (Fiscal year ended Dec 31, 2025), +105% vs $39.0M a year earlier, per its 10-K filed Mar 2026.
Was Eton Pharmaceuticals profitable in FY2025?
No: net income was −$4.60M and operating income −$840K in FY2025.
What was Eton Pharmaceuticals's revenue in Q3 2026?
$57.9M (+157% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.